Home / World News / Business / Sun Pharma to acquire Ranbaxy in $4 billion deal
Sun-Pharma

Sun Pharma to acquire Ranbaxy in $4 billion deal

Sun Pharma and Ranbaxy Laboratories announced that they have entered into definitive agreements pursuant to which the former will acquire 100% of Ranbaxy in an all-stock transaction. The deal being termed as a “landmark transaction”, has been estimated at $4 billion.

Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own. The exchange ratio represents an implied value of Rs 457 for each Ranbaxy share, a premium of 18% to Ranbaxy’s 30-day volume-weighted average share price and a premium of 24.3% to Ranbaxy’s 60-day volume-weighted average share price, in each case, as of the close of business on April 4, 2014, said the statement.

The combination of Sun Pharma and Ranbaxy will be the fifth-largest specialty generics company in the world and the largest pharmaceutical company in India.

 

 

About satyamevjayate

Satyamevjayates.com is a smart, intelligent, quirky, witty content portal that targets a young audience. Our stories will inform, educate and entertain the audience across a number of domains. Satyamevjayates.com team aims to track the planet and bring the “you must know about” movies, music, politics, fashion, style, entertainment, sports, and fitness and tech stories straight to you…

Facebook

Get the Facebook Likebox Slider Pro for WordPress